The company said in its statement that its restructuring plan is intended as a first step to make it “more attractive to both financial and strategic partners."
Along with employee cuts, several senior members of the executive team are departing as well.
https://www.biopharmadive.com/news/athersys-layoffs-restructuring-stroke-trial/624971/